ALPINE WOODS CAPITAL INVESTORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1226886 PURCHASE, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$442,190

+$121,402 QoQ

Shares Held

3,500

-32.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,438

of 2,266 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALPINE WOODS CAPITAL INVESTORS, LLC holds $30,863,002 across 6 Drug Manufacturers - General names. GILD ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	25,029	$9,063,501
2	ABBV	AbbVie Inc.	30,836	$7,759,571
3	JNJ	Johnson & Johnson	26,009	$6,605,505
4	LLY	ELI LILLY & Co	5,061	$6,070,315
5	BMY	Bristol Myers Squibb Co	16,000	$921,920
6	GILD	Gilead Sciences, Inc. This page	3,500	$442,190

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$442,190	3,500	-32.7%	Shares	Sole	2026-08-07
2022-09-30	$320,788	5,200	0.0%	Shares	Sole	2022-10-31
2022-06-30	$321,412	5,200	0.0%	Shares	Sole	2022-08-02
2022-03-31	$309,140	5,200	0.0%	Shares	Sole	2022-05-10
2021-12-31	$377,572	5,200	0.0%	Shares	Sole	2022-02-03
2021-09-30	$363,220	5,200	0.0%	Shares	Sole	2021-11-12
2021-06-30	$358,072	5,200	-7.1%	Shares	Sole	2021-08-09
2021-03-31	$361,928	5,600	-3.4%	Shares	Sole	2021-05-11
2020-12-31	$337,908	5,800	-94.5%	Shares	Sole	2021-02-01
2020-09-30	$6,721,583	106,371	+116.3%	Shares	Sole	2020-11-02
2020-06-30	$3,784,447	49,187	+16.3%	Shares	Sole	2020-08-10
2020-03-31	$3,162,348	42,300	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.